ArticleFrontiers in oncology2023

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.

Kang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.